Olon S.P.A.
2 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
3
Ending by 2030
Dec 2029
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 2 fees due Dec 2 to 25, 2026 · next Dec 2
- 2 fees due May 21 to 26, 2027 · next May 21
- 1 fee due Jul 21, 2027The maintenance fee for Process for the preparation of indanamine derivatives and new synthesis intermediates (US 10,538,479) comes due Jul 21, 2027. Unpaid by Jan 21, 2028, it lapses early.
- 1 fee due Oct 19, 2027The maintenance fee for Process for the preparation of unsaturated trifluoromethanesulfonate steroid derivatives (US 9,315,541) comes due Oct 19, 2027. Unpaid by Apr 19, 2028, it lapses early.
Recent changes
- 1 of the patents on this record was granted since Aug 17, 2026
- 1 term has ended since Aug 17, 2026
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,935,818 | Process for the preparation and purification of valgancyclovir hydrochloride In force · From the USPTO record | In force | From the USPTO record | |
| US 8,519,160 | Process for the preparation of rotigotine In force · From the USPTO record | In force | From the USPTO record | |
| US 8,313,922 | Process for the production of daptomycin In force · From the USPTO record | In force | From the USPTO record | |
| US 9,447,109 | Crystalline salts of asenapine In force · From the USPTO record | In force | From the USPTO record | |
| US 9,045,515 | Procedure for the purification of tiacumicin B In force · From the USPTO record | In force | From the USPTO record | |
| US 9,970,041 | Procedure for the production of tiacumicin B In force · From the USPTO record | In force | From the USPTO record | |
| US 9,340,571 | Process for the purification of abiraterone acetate In force · From the USPTO record | In force | From the USPTO record | |
| US 9,556,219 | Procedure for the preparation of abiraterone acetate and intermediates thereof In force · From the USPTO record | In force | From the USPTO record | |
| US 9,630,987 | Procedure for the preparation of abiraterone acetate and intermediates thereof In force · From the USPTO record | In force | From the USPTO record | |
| US 9,315,541 | Process for the preparation of unsaturated trifluoromethanesulfonate steroid derivatives In force · From the USPTO record | In force | From the USPTO record |
Also on record, not counted in the 21: 2 patents in force now held by others · 10 lapsed for an unpaid fee · 3 ended at full term. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
2 pending · 2 abandoned · 16 no status recorded